Microfluidic chip, also known as Lab-on-chip, is a scientific technology whose main feature is the manipulation of fluids in micron-scale space. At present, the mainstream form of microfluidic chip refers to the integration or basic integration of basic operating units such as sample preparation, reaction, separation, detection, cell culture, sorting, lysis, etc. involved in the fields of chemistry and biology into a piece of several square centimeters or even on smaller chips, a network of microchannels is formed, with controllable fluids running through the entire system. It is a technology used to realize various functions in different laboratories such as conventional chemistry, biology, materials, and optics. The largest industrialization scenario of microfluidics lies in in vitro diagnostics.

The global Microfluidic Technology (POCT Field) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Microfluidic Technology (POCT Field) Industry Forecast” looks at past sales and reviews total world Microfluidic Technology (POCT Field) sales in 2022, providing a comprehensive analysis by region and market sector of projected Microfluidic Technology (POCT Field) sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Microfluidic Technology (POCT Field) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Microfluidic Technology (POCT Field) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microfluidic Technology (POCT Field) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microfluidic Technology (POCT Field) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microfluidic Technology (POCT Field).

The United States market for Microfluidic Technology (POCT Field) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The China market for Microfluidic Technology (POCT Field) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The Europe market for Microfluidic Technology (POCT Field) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Microfluidic Technology (POCT Field) players cover Thermofisher, Parallel Fluidics, Roche, Abbott Laboratories, Danaher Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Microfluidic Technology (POCT Field) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Silicon Materials
• Glass Quartz Material
• Organic High Molecular Polymer Materials
• Paper Chip Material

Segmentation by Application:

• Medical Disease Diagnosis
• Pet/Animal and Plant Pathogen Detection
• Agricultural Disease Detection
• Food Safety Testing

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermofisher
• Parallel Fluidics
• Roche
• Abbott Laboratories
• Danaher Life Sciences
• Cepheid
• BioMérieux
• Micronit
• Bio-Rad Laboratories
• Zoetis
• Agilent Technologies
• Hologic
• Diasorin
• Qiagen
• Illumina
• Micropoint Bioscience
• Singleronbio
• Dichbio
• Hochuen Medical Technology Co., Ltd.
• Kexunanalychip
• Haolitech
• Honraymed
• Digifluidic
• Lansionbio
• Each-reach
• Whchip
• Capitalbiotech
• Bai-care
• Bohui-tech
• Tinkerbio
• Shenzhen Xike Biomedical Technology Co., Ltd.
• Newscen
• Seamaty